Bradykinin-2 receptor antagonist, HOE 140, prevents the development of delayed onset muscle soreness in female and male rats

Jeppe Nørgaard Poulsen, Thomas Graven-Nielsen, Parisa Gazerani

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2018
Publication statusPublished - 2018
Event17th World Congress on Pain, IASP 2018 - Boston, MA, United States
Duration: 12 Sep 201816 Sep 2018

Conference

Conference17th World Congress on Pain, IASP 2018
CountryUnited States
CityBoston, MA
Period12/09/201816/09/2018

Cite this

@conference{26573d889aab405094c3ff083cc66960,
title = "Bradykinin-2 receptor antagonist, HOE 140, prevents the development of delayed onset muscle soreness in female and male rats",
author = "Poulsen, {Jeppe N{\o}rgaard} and Thomas Graven-Nielsen and Parisa Gazerani",
year = "2018",
language = "English",
note = "17th World Congress on Pain, IASP 2018 ; Conference date: 12-09-2018 Through 16-09-2018",

}

Poulsen, JN, Graven-Nielsen, T & Gazerani, P 2018, 'Bradykinin-2 receptor antagonist, HOE 140, prevents the development of delayed onset muscle soreness in female and male rats' 17th World Congress on Pain, IASP 2018, Boston, MA, United States, 12/09/2018 - 16/09/2018, .

Bradykinin-2 receptor antagonist, HOE 140, prevents the development of delayed onset muscle soreness in female and male rats. / Poulsen, Jeppe Nørgaard; Graven-Nielsen, Thomas; Gazerani, Parisa.

2018. Abstract from 17th World Congress on Pain, IASP 2018, Boston, MA, United States.

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

TY - ABST

T1 - Bradykinin-2 receptor antagonist, HOE 140, prevents the development of delayed onset muscle soreness in female and male rats

AU - Poulsen, Jeppe Nørgaard

AU - Graven-Nielsen, Thomas

AU - Gazerani, Parisa

PY - 2018

Y1 - 2018

M3 - Conference abstract for conference

ER -